Clinical Trial Update: Valproic Acid in Childhood Progressive Brain Tumors [Phase 1]

View source ↗

Summary

The trial withdrawal notice states that the Phase 1 study of valproic acid for childhood progressive brain tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Glioma
• Medulloblastoma

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Pediatric Brain Tumor, Glioma | Phase 1 | Status: WITHDRAWN